Skip to main content
Top
Published in: Supportive Care in Cancer 1/2021

01-01-2021 | Acupuncture | Letter to the Editor

In reply to “could acupuncture be a treatment option for cancer patients with attitudinal barriers to pharmacological pain management?” by Kako, Kajiwara, and Kobayashi

Authors: Kevin T. Liou, Jun J. Mao

Published in: Supportive Care in Cancer | Issue 1/2021

Login to get access

Excerpt

We appreciate the correspondence regarding our article [1]. Kako et al. commented that patients’ experiences with acupuncture are important factors to consider in our study on pain management preferences. We did not assess patients’ prior use or experiences with acupuncture. However, our study used a validated instrument to evaluate patients’ attitudes and beliefs about acupuncture, including their expectations about benefits; these factors are often shaped by patients’ prior experiences with acupuncture [2, 3]. We adjusted for these attitudes and beliefs in our analyses, and we still found a significant association between acupuncture preference and fear of analgesic side effects. These results suggest that patients’ attitudes and beliefs about acupuncture are not the only factors influencing acupuncture preference. …
Literature
2.
go back to reference Bauml JM, Chokshi S, Schapira MM, Im EO, Li SQ, Langer CJ, Ibrahim SA, Mao JJ (2015) Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer 121:2431–2438 Bauml JM, Chokshi S, Schapira MM, Im EO, Li SQ, Langer CJ, Ibrahim SA, Mao JJ (2015) Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer 121:2431–2438
3.
go back to reference Mao JJ, Palmer SC, Desai K, Li SQ, Armstrong K, Xie SX (2012) Development and validation of an instrument for measuring attitudes and beliefs about complementary and alternative medicine (CAM) use among cancer patients. Evid Based Complement Alternat Med. https://doi.org/10.1155/2012/798098 Mao JJ, Palmer SC, Desai K, Li SQ, Armstrong K, Xie SX (2012) Development and validation of an instrument for measuring attitudes and beliefs about complementary and alternative medicine (CAM) use among cancer patients. Evid Based Complement Alternat Med. https://​doi.​org/​10.​1155/​2012/​798098
4.
go back to reference Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(8):977–1007. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(8):977–1007.
Metadata
Title
In reply to “could acupuncture be a treatment option for cancer patients with attitudinal barriers to pharmacological pain management?” by Kako, Kajiwara, and Kobayashi
Authors
Kevin T. Liou
Jun J. Mao
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05844-9

Other articles of this Issue 1/2021

Supportive Care in Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine